Smith & Nephew is a medical-technology company focused on orthopaedics, sports medicine and advanced wound management. Its products include joint implants, arthroscopy systems and dressings used in surgery and chronic-wound care. Hospitals, surgeons and healthcare systems worldwide are the primary customers for these devices and consumables.
| Year | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| 2022 | 5,215 | — | 223 | — |
| 2023 | 5,549 | 6.4% | 263 | 17.9% |
| 2024 | 5,810 | 4.7% | 412 | 56.6% |
| 2025 | 6,164 | 6.1% | 625 | 51.7% |
All markets — KeepWinning global stock screener
Other companies on London Stock Exchange: Rentokil Initial plc (RTO), M&G plc (MNG), Marks and Spencer Group plc (MKS), Beazley plc (BEZ), Smiths Group plc (SMIN), Pearson plc (PSON)